Has Saad Shakir received payments from drug or device companies?

Yes. Drug and device makers reported $66,377 in general payments to Saad Shakir across 828 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Saad Shakir did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Saad Shakir come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Saad Shakir

Psychiatry · San Jose, CANPI 1245367374

Payments from drug & device makers

$66,377in general payments, 2019–2025

Across 828 payments — averaging $80.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$28K
Ironshore Pharmaceuticals Inc.$24K
Takeda Pharmaceuticals U.S.A., Inc.$2K
Neurocrine Biosciences, Inc.$1K
Sunovion Pharmaceuticals Inc.$1K
Lundbeck LLC$1K
plus $8K from 30 others

What the payments were for

Consulting fees$1,0002%
Speaking & faculty fees$42,06063%
Travel & lodging$5,8289%
Food & beverage$17,19426%
Education$2950%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	136	$28,226
Ironshore Pharmaceuticals Inc.	89	$24,184
Takeda Pharmaceuticals U.S.A., Inc.	83	$1,696
Neurocrine Biosciences, Inc.	67	$1,382
Sunovion Pharmaceuticals Inc.	75	$1,244
Lundbeck LLC	73	$1,207
Brainsway USA Inc	2	$1,075
Otsuka America Pharmaceutical, Inc.	65	$1,028
Teva Pharmaceuticals USA, Inc.	36	$975
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	33	$881
Neuronetics, Inc.	2	$770
Vanda Pharmaceuticals Inc.	35	$698
Alkermes, Inc.	15	$427
Bausch Health US, LLC	18	$394
Avanir Pharmaceuticals, Inc.	15	$357
AbbVie(2 entities)	14	$267
Jazz Pharmaceuticals Inc.	7	$263
Shire North American Group Inc	13	$243
Alfasigma USA, Inc.	7	$162
Eisai Inc.	7	$133
Corium, LLC	5	$117
Adlon Therapeutics L.p.	5	$111
Merck	5	$90
Amgen	3	$76
Indivior Inc.	4	$71
Vertical Pharmaceuticals, LLC	3	$65
Noven Pharmaceuticals, Inc.	1	$36
Novartis	2	$33
Livanova USA, Inc.	1	$27
Supernus Pharmaceuticals, Inc.	1	$24
Biohaven Pharmaceuticals, Inc.	1	$21
Noven Therapeutics, LLC	1	$21
Nalpropion Pharmaceuticals LLC	1	$20
Almatica Pharma LLC	1	$18
Collegium Pharmaceutical, Inc.	1	$17
MDD US Operations, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$25,418
Jornay PM 20mg capsules (Bottle of 100)$12,758
JORNAY PM$9,722
Brainsway Deep TMS$1,000
NEUROSTAR TMS THERAPY SYSTEM$770
SUNOSI$125
AJOVY$125

How this compares

$66,377 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in San Jose

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →